Novo Nordisk grant to Pia Rantakari and Klaus Elenius
The Novo Nordisk Foundation awarded 2024 grants to five researchers from the University of Turku, totaling approximately €2,204,294.
Among the grant recipients were:
Docent, InFLAMES and Turku Bioscience group leader Pia Rantakari. Her research titled Unveiling the Role of Pituitary Gland Macrophages in Polycystic Ovarian Syndrome: Towards Novel Therapeutics got DKK 2.997.685 (approx. 401 988 €) funding.
Professor, BioCity Turku Director, Turku Bioscience group leader Klaus Elenius. His research titled Overcoming Cancer drUg Resistance by targeting ERBB3 (CURE) got DKK 5.981.741 (approx. 802 149 €) funding.
Warm congratulations!
Recent Posts
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025
- The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for Read moreOctober 30, 2025
- Guillaume Jacquemet and Cecilia Sahlgren receive funding for the Research Council of Finland Centre of Excellence in Immune-Endothelial Interactions (IMMENs) Associate Professor Guillaume Jacquemet, our Group Leader, and Professor Cecilia Sahlgren, our affiliated Group Leader, Read moreOctober 30, 2025
- Registration to AI2Med imaging event is now open! Registration for AI2Med Turku 2025 is open! The event is organized by the Turku PET Read moreOctober 21, 2025
- Jonna Alanko receives the Young Investigator Award from the Scandinavian Society for Immunology Jonna Alanko has received the Young Investigator Award of the Scandinavian Society for Immunology. The Read moreOctober 17, 2025
- Professor Riitta Lahesmaa awarded Johnny Ludvigsson Prize for Outstanding Nordic Researcher Professor Riitta Lahesmaa was awarded Johnny Ludvigsson Prize for Outstanding Nordic Researcher. The prize is Read moreOctober 16, 2025